NCT04567082Completed
Proteome- and Methylation Profiles in Oropharyngeal Cancer
Source: ClinicalTrials.gov · Last updated 2 May 2024
Brief summary (registry, in English)
This clinical study aims to evaluate proteome- and methylation profiles in saliva in patients with oropharyngeal cancers
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 45 (actual)
- First submitted
- 23 Sept 2020
- Start date
- 25 Sept 2020
- Primary completion date
- 31 Jan 2024
- Lead sponsor
- Aalborg University Hospital
- Diseases
- Head and neck cancer
- NCT number
- NCT04567082
What you commit to
- Study type: Observational
- Participants enrolled: 45
- From 25 Sept 2020 to the primary completion date, 31 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other active cancer
- Active cancer
Other
- Uncontrolled comorbidity
- Unable to give informed consent
- Control group:
- Uncontrolled comorbidity
- Unable to give informed consent
Who the study is looking for
- Written informed consent
- Verified oropharyngeal squamous cell carcinoma
- Written informed consent
- Normal ENT examination
Criteria the registry did not label
- Cancer group:
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Otolaryngology - Head and Neck Surgery Coordinator of this site? Confirm its status | Aalborg | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.